Anebulo Pharmaceuticals Inc. (ANEB)

factsheet Factsheet
  • Value Research Rating market-capitalisation-info
    Not Applicable
  • Market Capitalisation market-capitalisation-info $72 Mln
  • Price to Earnings Ratio price-to-earning --
  • 12 Month Earnings monthly-earning $-5 Mln

Anebulo Pharmaceuticals Inc. (ANEB) Share Price

$2.72

As on 29-Feb-2024 16:00 EST

up-down-arrow $-0.06-2.16%

  • Prev Close info

    $2.78

  • Day's Openinfo

    $3.14

  • Today's Highinfo

    $3.14

  • Today's Lowinfo

    $2.72

  • Today's Volumeinfo

    2,277

  • 52 Week rangeinfo

    $1.62 - 4.05

Please wait...

Anebulo Pharmaceuticals Inc. (ANEB) Stock Performance

YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Anebulo Pharmaceuticals (ANEB)
12.40 12.16 26.51 -6.21 -- -- --
S&P BSE Sensex*
2.08 2.78 10.09 25.07 14.52 15.51 13.32
S&P Small-Cap 600#
-5.82 -5.34 -13.73 -6.30 5.30 2.98 5.53
As on 29-Feb-2024  |  *As on 01-Mar-2024  |  #As on 26-Oct-2023
2023
2022
Anebulo Pharmaceuticals (ANEB)
-0.15 -60.59
S&P Small-Cap 600
13.89 -17.42
S&P BSE Sensex
18.74 4.44

Valuation Score

Stock
Peer Median
Please wait...

Growth & Efficiency

Stock
Peer Median
Please wait...

Solvency

Is there a threat to this company's solvency in the future?

Financial Manipulation

Can creative accounting be detected through the financial numbers?

Anebulo Pharmaceuticals Inc. (ANEB) Peer Comparison

search
search
search
search
    Please wait...

    Valuation Chart of Anebulo Pharmaceuticals Inc. (ANEB)

      Please wait...
        Please wait...

        Financials

        Please wait...
        Please wait...
        Please wait...

        Shareholding Pattern

        Other details of Anebulo Pharmaceuticals Inc. (ANEB)

        Founder & Chairman

        Dr. Joseph F. Lawler M.D., Ph.D.

        Chief Scientific Officer

        Dr. Kenneth C. Cundy Ph.D.

        Headquarters

        Lakeway, TX

        FAQs for Anebulo Pharmaceuticals Inc. (ANEB)

        The total asset value of Anebulo Pharmaceuticals Inc. (ANEB) stood at $ 12 Mln as on 31-Dec-23

        The share price of Anebulo Pharmaceuticals Inc. (ANEB) is $2.72 (NASDAQ) as of 29-Feb-2024 16:00 EST. Anebulo Pharmaceuticals Inc. (ANEB) has given a return of -6.21% in the last 1 years.

        Anebulo Pharmaceuticals Inc. (ANEB) has a market capitalisation of $ 72 Mln as on 29-Feb-2024. As per Value Research classification, it is a Small Cap company.

        The P/B ratio of Anebulo Pharmaceuticals Inc. (ANEB) is 11.11 times as on 29-Feb-2024, a 2.73% premium to its peers’ median range of 2.98 times.

        Since, TTM earnings of Anebulo Pharmaceuticals Inc. (ANEB) is negative, P/E ratio is not available.

        Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
        Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
        Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
        Step 4. Search for the Anebulo Pharmaceuticals Inc. (ANEB) and enter the required number of quantities and click on buy to purchase the shares of Anebulo Pharmaceuticals Inc. (ANEB).

        Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing solutions for people suffering from acute cannabinoid intoxication (ACI) and substance addiction. The company's lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist, which is in a Phase II clinical trial to address the unmet medical need for a specific antidote for ACI. Anebulo Pharmaceuticals, Inc. was incorporated in 2020 and is based in Lakeway, Texas. Address: 1017 Ranch Road 620 South, Lakeway, TX, United States, 78734

        The CEO & director of Dr. Joseph F. Lawler M.D., Ph.D.. is Anebulo Pharmaceuticals Inc. (ANEB), and CFO & Sr. VP is Dr. Kenneth C. Cundy Ph.D..

        The promoters of Anebulo Pharmaceuticals Inc. (ANEB) have pledged 0% of the total equity as on Dec-23.

        Anebulo Pharmaceuticals Inc. (ANEB) Ratios
        Return on equity(%)
        -91.42
        Return on capital employed(%)
        -91.42
        Debt-to-equity ratio
        --
        Dividend yield(%)
        --

        No, TTM profit after tax of Anebulo Pharmaceuticals Inc. (ANEB) was $-5 Mln.

        Edit peer-selector-edit
        Please wait...
        Please wait...

        Key Facts

        • Market cap market-cap-information $72.48 Mln
        • Revenue (TTM)revenue-information $0.00 Mln
        • Earnings (TTM) earning-information $-4.99 Mln
        • Cash date-information $6.64 Mln
        • Total Debt info $0.00 Mln
        • Insider's Holding 65.38%
        • Liquidity liquidity Moderate
        • 52 Week range week-range $1.62 - 4.05
        • Shares outstanding share-outstanding 25,933,200
        • 5 Years Aggregate:

          CFO: $-25.77 Mln

          EBITDA: $-25.83 Mln

          Net Profit: $-79.25 Mln

        About The Company

        • IPO Date 07-May-2021
        • Founder & Chairman Dr. Joseph F. Lawler M.D., Ph.D.
        • Chief Scientific Officer Dr. Kenneth C. Cundy Ph.D.
        • Listing key-listing NASDAQ: ANEB
        • Country United States
        • Headquarters headquarters Lakeway, TX
        • Website website https://www.anebulo.com
        • Business

          Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing solutions for people suffering from acute cannabinoid intoxication (ACI) and substance addiction. The company's lead product candidate is ANEB-001, a small...  molecule cannabinoid receptor antagonist, which is in a Phase II clinical trial to address the unmet medical need for a specific antidote for ACI. Anebulo Pharmaceuticals, Inc. was incorporated in 2020 and is based in Lakeway, Texas. Address: 1017 Ranch Road 620 South, Lakeway, TX, United States, 78734  Read more

        share-fund-plan-icon